Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014
Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014
复制标题
DOI：
10.1161/circheartfailure.119.005929
复制
发表时间：
2019-12-01
影响因子：
9.7
通讯作者：
Barsness, Gregory W.
中科院分区：
文献类型：
--
作者：
Vallabhajosyula, Saraschandra;Prasad, Abhiram;Barsness, Gregory W.
背景：体外膜肺氧合(ECMO)在急性心肌梗死(AMI)治疗中的应用日益增多，但国内大规模数据有限。方法：利用2000年至2014年全国住院患者样本数据库，确定使用ECMO的急性心肌梗死患者的回顾性队列。经皮冠状动脉介入治疗、主动脉内球囊反搏和经皮左心室辅助装置(LVAD)的使用也在这一人群中被发现。值得关注的结果包括单独使用ECMO和伴随程序(经皮冠状动脉介入治疗、主动脉内球囊反搏和经皮左冠状动脉前降支)、住院死亡率和资源利用的时间趋势。结果：在近900万入院的急性心肌梗死患者中，2962例使用了ECMO(
Background: Extracorporeal membrane oxygenation (ECMO) is increasingly used in acute myocardial infarction (AMI); however, there are limited large-scale national data. Methods: Using the National Inpatient Sample database from 2000 to 2014, a retrospective cohort of AMI utilizing ECMO was identified. Use of percutaneous coronary intervention, intra-aortic balloon pump, and percutaneous left ventricular assist device (LVAD) was also identified in this population. Outcomes of interest included temporal trends in utilization of ECMO alone and with concomitant procedures (percutaneous coronary intervention, intra-aortic balloon pump, and percutaneous LVAD), in-hospital mortality, and resource utilization. Results: In approximate to 9 million AMI admissions, ECMO was used in 2962 (